- US12616698utility2026Methods for Reducing Liver Fat and for Treating Fatty Liver Disorders0 cites
- US12616685utility2026Concomitant Administration of Glucocorticoid Receptor Modulator Relacorilant and CYP2C9 Substrates0 cites
- US12433882utility2025Treatments for Amyotrophic Lateral Sclerosis Using Dazucorilant0 cites
- US12370188utility2025Formulations of Dazucorilant, a Glucocorticoid Receptor Modulator0 cites
- US12336985utility2025Methods for Shrinking Pituitary Tumors0 cites
- US12290551utility2025Methods for Imaging and Treatment of Somatostatin-receptor Positive Tumors0 cites
- US12180186utility2024Quaternary Indazole Glucocorticoid Receptor Antagonists0 cites
- US12171760utility2024Use of Glucocorticoid Receptor Modulators to Potentiate Checkpoint Inhibitors0 cites
- US12152028utility2024Methods of Preparing Heteroaryl-ketone Fused Azadecalin Glucocorticoid Receptor Modulators0 cites
- US12144812utility2024Formulations of Pyrimidine Cyclohexyl Glucocorticoid Receptor Modulators0 cites
- US12139463utility2024Polymorphs of Pyrimidine Cyclohexyl Glucocorticoid Receptor Modulators0 cites
- US12109272utility2024Intermittent Dosing of Glucocorticoid Receptor Modulators for the Treatment of Ovarian and Other Cancers0 cites
- US12102642utility2024Treatment of Hypercoagulopathy in Cushing's Syndrome by Administration of Glucocorticoid Receptor Modulators0 cites
- US12098144utility2024Piperazine Indazole Glucocorticoid Receptor Antagonists0 cites
- US12098141utility2024Bicyclic Indazole Glucocorticoid Receptor Antagonists0 cites
- US12018001utility2024Pyrimidine Cyclohexenyl Glucocorticoid Receptor Modulators0 cites
- US12005055utility2024Methods for Shrinking Pituitary Tumors0 cites
Page 1 of 2Next →